There is a lack of substantial evidence that rivaroxaban will have its desired effect when used as recommended in labeling," said Food and Drug Administration staff in documents released on Tuesday.
via msnbc.msn.com
There is a lack of substantial evidence that rivaroxaban will have its desired effect when used as recommended in labeling," said Food and Drug Administration staff in documents released on Tuesday.
No comments:
Post a Comment